National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

MART-1 antigen
A tumor-associated melanocytic differentiation antigen. Vaccination with MART-1 antigen may stimulate a host cytotoxic T-cell response against tumor cells expressing the melanocytic differentiation antigen, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Antigen LB39-AA
Antigen SK29-AA
MART-1
MART-1 Tumor Antigen
Melan A
Melan-A Protein
Melanoma Antigen Recognized by T-Cells 1
MLANA
MLANA Protein



Previous:mapatumumab, marcellomycin, marijuana, marimastat, Marinol
Next:MART-1:26-35(27L) peptide vaccine, MART-1:27-35 peptide vaccine, mast cell stabilizer TF002, Matulane, matuzumab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov